Ipswich Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,865
Closed -$483K 181
2019
Q3
$483K Sell
4,865
-255
-5% -$24.2K 0.15% 118
2019
Q2
$473K Sell
5,120
-50
-1% -$4.75K 0.15% 118
2019
Q1
$488K Sell
5,170
-485
-9% -$42.4K 0.16% 115
2018
Q4
$362K Sell
5,655
-625
-10% -$46.1K 0.13% 120
2018
Q3
$562K Buy
+6,280
New +$555K 0.19% 102
2018
Q2
Sell
-16,179
Closed -$1.44M 155
2018
Q1
$1.44M Sell
16,179
-1,609
-9% -$154K 0.61% 51
2017
Q4
$1.86M Sell
17,788
-8,685
-33% -$980K 0.79% 41
2017
Q3
$3.86M Buy
26,473
+70
+0.3% +$9.54K 1.73% 20
2017
Q2
$3.43M Sell
26,403
-2,195
-8% -$269K 1.61% 21
2017
Q1
$3.56M Buy
28,598
+1,040
+4% +$124K 1.55% 24
2016
Q4
$3.19M Buy
27,558
+2,433
+10% +$271K 1.44% 24
2016
Q3
$2.63M Sell
25,125
-52
-0.2% -$5.63K 1.28% 28
2016
Q2
$2.48M Buy
25,177
+315
+1% +$32.6K 1.23% 32
2016
Q1
$2.55M Sell
24,862
-3,878
-13% -$399K 1.21% 32
2015
Q4
$3.44M Buy
28,740
+2,215
+8% +$256K 1.55% 22
2015
Q3
$2.87M Buy
26,525
+1,535
+6% +$190K 1.37% 29
2015
Q2
$2.89M Sell
24,990
-1,520
-6% -$174K 1.3% 31
2015
Q1
$3.06M Sell
26,510
-1,310
-5% -$157K 1.34% 28
2014
Q4
$3.11M Buy
27,820
+80
+0.3% +$8.44K 1.33% 31
2014
Q3
$2.63M Sell
27,740
-280
-1% -$25.3K 1.12% 38
2014
Q2
$2.41M Buy
28,020
+6,410
+30% +$487K 0.93% 45
2014
Q1
$1.51M Buy
21,610
+17,560
+434% +$1.39M 0.65% 50
2013
Q4
$342K Buy
4,050
+650
+19% +$51.4K 0.14% 103
2013
Q3
$262K Buy
+3,400
New +$238K 0.12% 114

Other funds holding CELG

Ipswich Investment Management's CELG Position: Q4 2019 in Review

Ipswich Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,865 shares — an estimated $483K sold.

Ipswich Investment Management first reported a position in CELG in Q3 2013 and held it in 24 quarters. The position peaked at $3.86M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ipswich Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ipswich Investment Management sold 4,865 Celgene Corp shares in Q4 2019, an estimated $483K.
  • Ipswich Investment Management first reported a position in Celgene Corp in Q3 2013 and held it in 24 quarters.
  • Ipswich Investment Management's Celgene Corp position peaked at $3.86M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ipswich Investment Management's 13F filing for Q4 2019, filed 8 Jan 2020.